原发性肝癌经肝动脉升压化疗栓塞三年随访结果分析

Angiotens Ⅱ in infusion induced hypertension and chemoembolization for primary liver cancer-A clinical analysis of 85 cases w ith 3-year follow-up

摘要: 自1992年5月至1993年4月，对85例原发性肝癌进行肝动脉血管紧张素Ⅱ介导的升压化疗栓塞（IHCE），三年随访结果1年生存率76．4%（65/85），2年生存率48．2%（41/85），3年生存率32．9%（28/85）。文中对IHCE治疗的机理进行探讨，并与TCE相比较。提出IHCE可取代TCE并作为不可切除肝癌的首选疗法。

Abstract: Advanced primary liver cancer (PLC) was treatedin 85 cases by Angiotensin Ⅱ infusion induced hypertension and chemoembolization (IHCE) from May 1992 to April 1993. 65 cases(76.4%)have survived more than 1 year, 41 cases(48.2%) survived more than 2 years and 28 cases(32.9%) more than 3 years. IHCE increas-es antitumor effect of TCE, can be the first choice for unresectable PLC instead of TCE.